14-day Premium Trial Subscription Try For FreeTry Free
Shares of thinly-traded nano-cap biotech Cellect Biotechnology Ltd - ADR (NASDAQ: APOP) are advancing strongly Wednesday. The Israeli company said it has entered into a commercial binding Letter of In

CVS, UNH among premarket gainers

02:15pm, Wednesday, 04'th Mar 2020
Cellect Biotechnology (NASDAQ:APOP) +38% on Canndoc deal.Dynatronics (NASDAQ:DYNT) +28%.AIM ImmunoTech (NYSEMKT:AIM) +24% on recent announcements on Covid-19 front.Arcturus Therapeutics Holdings (NA
Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology that enables the functional selection of stem cells, today announced that its Board of Directors has approved, and the c
CELLECT BIOTECH/S (NASDAQ:APOP) and LeMaitre Vascular (NASDAQ:LMAT) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength
We can readily understand why investors are attracted to unprofitable companies. For example, although...

Company News For Jan 8, 2020

03:05pm, Wednesday, 08'th Jan 2020
Companies In The News Are: APOP, APA, MCHP, CTIB
Cellect Biotechnology Ltd. (Nasdaq: APOP) ("Cellect" or the "Company"), a developer of innovative technology which enables the functional selection of stem cells, today announced it has entered into a
Benzinga Pro's Stocks To Watch For Tuesday Tesla (TSLA)  - Tesla's Elon Musk hosted an event in Shanghai Monday evening. While the exec announced Tesla will manufacture its electric Model Y SUV in Ch
Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of innovative technology which enables the functional selection of stem cells, received official communication from two jurisdictions, the Europe
Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology to enable the functional selection of stem cells, has received approval to initiate the trial in the U.S. to evaluate th
TEL AVIV, Israel , Nov. 19, 2019 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported f
If you're interested in Cellect Biotechnology Ltd. (NASDAQ:APOP), then you might want to consider its beta (a measure...
Tel Aviv, Israel, Nov. 7, 2019 /PRNewswire/ -- Cellect Biotechnology Ltd. (APOP), a developer of innovative technology which enables the functional selection of stem cells, announced today that on No
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE